Prostate implant evaluation using tumour control probability--the effect of input parameters.

In this paper, we examine the effect of treatment parameters in a model used to evaluate permanent prostate implants. The model considers the prostate to be composed of 12 sub-sections, each sub-section is assigned a cell density based on the probability of finding cancer foci in that sub-section. Wasted dose as a result of the dose rate from the implant falling below a level adequate to counteract repopulation was found to vary by 2-16% over the range of radiosensitivity and repopulation rates considered. Within the model, applied to five dose distributions, the uncertainty in the tumour control probability (TCP) values calculated for each sub-section as a result of differences in the model parameters, was found to be less than 12% in most cases for the good quality implants. The difference in TCP values was much larger for the poor quality implant. Substituting a heterogeneous distribution of alpha for a single mean value resulted in generally lower TCP values though introducing a cutoff value with a Gaussian distribution had a profound effect on the calculated values. Despite uncertainties in the parameters, the model was able to identify sub-sections at risk of local recurrence but as a result of these uncertainties, the TCP values can only be considered in the relative rather than absolute sense.

[1]  R Mohan,et al.  Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.

[2]  Annette Haworth,et al.  Assessment of i-125 prostate implants by tumor bioeffect. , 2004, International journal of radiation oncology, biology, physics.

[3]  R. Dale Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model. , 1989, The British journal of radiology.

[4]  X. Allen Li,et al.  HOW LOW IS THE / RATIO FOR PROSTATE CANCER? , 2003 .

[5]  David J Brenner,et al.  Hypofractionation for prostate cancer radiotherapy--what are the issues? , 2003, International journal of radiation oncology, biology, physics.

[6]  T E Schultheiss,et al.  Optimization of conformal radiation treatment of prostate cancer: report of a dose escalation study. , 1997, International journal of radiation oncology, biology, physics.

[7]  J D Fenwick,et al.  Predicting the radiation control probability of heterogeneous tumour ensembles: data analysis and parameter estimation using a closed-form expression. , 1998, Physics in medicine and biology.

[8]  J. Fowler,et al.  On cold spots in tumor subvolumes. , 2002, Medical physics.

[9]  Rick Chappell,et al.  Is α/β for prostate tumors really low? , 2001 .

[10]  A. Nahum,et al.  The delta-TCP concept: a clinically useful measure of tumor control probability. , 1999, International journal of radiation oncology, biology, physics.

[11]  M A Ebert,et al.  Viability of the EUD and TCP concepts as reliable dose indicators. , 2000, Physics in medicine and biology.

[12]  Warren D. D'Souza,et al.  Is the α/β ratio for prostate cancer low? , 2001 .

[13]  H. Kal,et al.  HOW LOW IS THE / RATIO FOR PROSTATE CANCER? , 2003 .

[14]  Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations. , 2003, Physics in medicine and biology.

[15]  D. Brenner,et al.  In response to Drs. King and Mayo: low α/β values for prostate appear to be independent of modeling details1 , 2000 .

[16]  J. Fowler,et al.  Selective boosting of tumor subvolumes. , 2000, International journal of radiation oncology, biology, physics.

[17]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[18]  R G Dale,et al.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.

[19]  C Busch,et al.  Modeling prostate cancer distributions. , 1999, Urology.

[20]  J H Hendry,et al.  A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. , 1998, International journal of radiation oncology, biology, physics.

[21]  M Goitein,et al.  Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. , 1996, International journal of radiation oncology, biology, physics.

[22]  C C Ling,et al.  Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. , 2001, International journal of radiation oncology, biology, physics.

[23]  J. Fowler,et al.  How low is the α/β ratio for prostate cancer? in regard to Wang et al., IJROBP 2003;55:194–203 , 2003 .

[24]  A. Renshaw,et al.  Defining the implant treatment volume for patients with low risk prostate cancer: does the anterior base need to be treated? , 1999, International journal of radiation oncology, biology, physics.

[25]  R. Stock,et al.  A dose-response study for I-125 prostate implants. , 1998, International journal of radiation oncology, biology, physics.

[26]  J. Battista,et al.  The influence of brachytherapy dose heterogeneity on estimates of α/β for prostate cancer , 2003 .

[27]  Jian Z. Wang,et al.  Evaluation of external beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose. , 2002, Medical physics.

[28]  Jian Z. Wang,et al.  Low α/β ratio for prostate cancer: in response to Dr. Fowler et al. , 2003 .

[29]  D. Brenner,et al.  Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .

[30]  M Goitein,et al.  Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumor. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  S Webb,et al.  A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.

[32]  Alexandru Daşu,et al.  Should single or distributed parameters be used to explain the steepness of tumour control probability curves? , 2003, Physics in medicine and biology.

[33]  D J Brenner,et al.  Fractionation and protraction for radiotherapy of prostate carcinoma. , 1999, International journal of radiation oncology, biology, physics.

[34]  Duchesne Gm,et al.  What is the alpha/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy. , 1999 .

[35]  T. Akimoto,et al.  Change in E-cadherin expression after X-ray irradiation of a human cancer cell line in vitro and in vivo. , 1998, International journal of radiation oncology, biology, physics.

[36]  A. Niemierko Reporting and analyzing dose distributions: a concept of equivalent uniform dose. , 1997, Medical physics.

[37]  H. Withers Biological Aspects of Conformal Therapy , 2000, Acta oncologica.

[38]  Sartaj Sahni,et al.  Leaf sequencing algorithms for segmented multileaf collimation. , 2003, Physics in medicine and biology.

[39]  A Brahme,et al.  Biologically effective uniform dose (D) for specification, report and comparison of dose response relations and treatment plans. , 2001, Physics in medicine and biology.

[40]  J. Fowler,et al.  A comment on proliferation rates in human prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[41]  S. Zavgorodni,et al.  Modeling dose response in the presence of spatial variations in dose rate. , 2000, Medical physics.

[42]  Jian Z. Wang,et al.  The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? , 2003 .

[43]  A Brahme,et al.  Dosimetric precision requirements in radiation therapy. , 1984, Acta radiologica. Oncology.

[44]  R G Dale,et al.  Dose-rate effects in targeted radiotherapy. , 1996, Physics in medicine and biology.

[45]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .